Ayala Pharmaceuticals logo
Ayala Pharmaceuticals AYLA

Annual report 2022
added 03-31-2023

report update icon

Ayala Pharmaceuticals Long Term Debt Current 2011-2026 | AYLA

Annual Long Term Debt Current Ayala Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
419 K - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
419 K 419 K 419 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
5.38 M - -15.15 % $ 60.3 M britainBritain
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
1.8 M $ 80.34 - $ 1.55 B usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.84 1.96 % $ 4.58 M chinaChina
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Adagene Adagene
ADAG
1.18 M $ 2.67 - $ 150 M chinaChina
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.57 - $ 8.59 B australiaAustralia
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
4.49 M $ 1.5 - $ 281 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
428 K - -45.71 % $ 1.2 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 222.03 - $ 5 B danmarkDanmark
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
BioNTech SE BioNTech SE
BNTX
39.5 M $ 110.34 - $ 27.2 B germanyGermany
Cabaletta Bio Cabaletta Bio
CABA
3.56 M $ 2.44 - $ 2.85 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Athira Pharma Athira Pharma
ATHA
414 K - - $ 269 M usaUSA
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 4.22 - $ 9.18 B israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.46 - $ 373 M britainBritain
Compugen Ltd. Compugen Ltd.
CGEN
768 K $ 1.71 - $ 153 M israelIsrael
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
224 M $ 14.52 - $ 4.49 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA